These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20460791)

  • 1. Formulation and evaluation of solid lipid nanoparticles of a water soluble drug: Zidovudine.
    Singh S; Dobhal AK; Jain A; Pandit JK; Chakraborty S
    Chem Pharm Bull (Tokyo); 2010 May; 58(5):650-5. PubMed ID: 20460791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique.
    Becker Peres L; Becker Peres L; de Araújo PHH; Sayer C
    Colloids Surf B Biointerfaces; 2016 Apr; 140():317-323. PubMed ID: 26764112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
    Garg A; Singh S
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solid lipid nanoparticles loaded with insulin by sodium cholate-phosphatidylcholine-based mixed micelles: preparation and characterization.
    Liu J; Gong T; Wang C; Zhong Z; Zhang Z
    Int J Pharm; 2007 Aug; 340(1-2):153-62. PubMed ID: 17428627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Solid Lipid Nanocarrier of Glibenclamide: A Factorial Design Approach with Response Surface Methodology.
    Pandey S; Patel P; Gupta A
    Curr Pharm Des; 2018; 24(16):1811-1820. PubMed ID: 29788881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
    Rawat MK; Jain A; Singh S
    J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticles as tool for enhanced ophthalmic delivery of vancomycin: a multidistrict-based microbiological study, solid lipid nanoparticles formulation and evaluation.
    Yousry C; Fahmy RH; Essam T; El-Laithy HM; Elkheshen SA
    Drug Dev Ind Pharm; 2016 Nov; 42(11):1752-62. PubMed ID: 27093938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefuroxime axetil loaded solid lipid nanoparticles for enhanced activity against S. aureus biofilm.
    Singh B; Vuddanda PR; M R V; Kumar V; Saxena PS; Singh S
    Colloids Surf B Biointerfaces; 2014 Sep; 121():92-8. PubMed ID: 24945607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation, characterization, and evaluation of gatifloxacin loaded solid lipid nanoparticles as colloidal ocular drug delivery system.
    Kalam MA; Sultana Y; Ali A; Aqil M; Mishra AK; Chuttani K
    J Drug Target; 2010 Apr; 18(3):191-204. PubMed ID: 19839712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Halobetasol propionate-loaded solid lipid nanoparticles (SLN) for skin targeting by topical delivery.
    Bikkad ML; Nathani AH; Mandlik SK; Shrotriya SN; Ranpise NS
    J Liposome Res; 2014 Jun; 24(2):113-23. PubMed ID: 24131382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Part I: Development and optimization of solid-lipid nanoparticles using Box-Behnken statistical design for ocular delivery of gatifloxacin.
    Abul Kalam M; Sultana Y; Ali A; Aqil M; Mishra AK; Aljuffali IA; Alshamsan A
    J Biomed Mater Res A; 2013 Jun; 101(6):1813-27. PubMed ID: 23255511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of Box-Behnken design for preparation of levofloxacin-loaded stearic acid solid lipid nanoparticles for ocular delivery: Optimization, in vitro release, ocular tolerance, and antibacterial activity.
    Baig MS; Ahad A; Aslam M; Imam SS; Aqil M; Ali A
    Int J Biol Macromol; 2016 Apr; 85():258-70. PubMed ID: 26740466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Strategic approaches for improving entrapment of hydrophilic peptide drugs by lipid nanoparticles.
    Yuan H; Jiang SP; Du YZ; Miao J; Zhang XG; Hu FQ
    Colloids Surf B Biointerfaces; 2009 May; 70(2):248-53. PubMed ID: 19185474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
    Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
    Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel method to produce solid lipid nanoparticles using n-butanol as an additional co-surfactant according to the o/w microemulsion quenching technique.
    Mojahedian MM; Daneshamouz S; Samani SM; Zargaran A
    Chem Phys Lipids; 2013 Sep; 174():32-8. PubMed ID: 23743405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effective encapsulation of a hydrophobic lipid-insoluble drug in solid lipid nanoparticles using a modified double emulsion solvent evaporation method.
    Nabi-Meibodi M; Vatanara A; Najafabadi AR; Rouini MR; Ramezani V; Gilani K; Etemadzadeh SM; Azadmanesh K
    Colloids Surf B Biointerfaces; 2013 Dec; 112():408-14. PubMed ID: 24036624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical characterization of sildenafil-loaded solid lipid nanoparticle dispersions (SLN) for pulmonary application.
    Paranjpe M; Finke JH; Richter C; Gothsch T; Kwade A; Büttgenbach S; Müller-Goymann CC
    Int J Pharm; 2014 Dec; 476(1-2):41-9. PubMed ID: 25261709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.